Sort
23,748 grants matching “melanoma”
Overcoming drug resistance using small molecule activators of protein phosphatase 2A
$228,958Jennifer D Black · University Of Nebraska Medical Center · R21 · FY2022 · CA
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY
$228,892Paul B Robbins · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
T CELL RESPONSE TO GENETICALLY ENGINEERED AND MATURED DC
$228,892University Of Connecticut Sch Of Med/Dnt · R01 · FY2000 · CA
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and....
$228,873Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2014 · CA
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade
$228,870Alexander Huang · University Of Pennsylvania · K08 · FY2019 · CA
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade
$228,870Alexander Huang · University Of Pennsylvania · K08 · FY2021 · CA
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade
$228,870Alexander Huang · University Of Pennsylvania · K08 · FY2022 · CA
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade
$228,870Alexander Huang · University Of Pennsylvania · K08 · FY2020 · CA
Project 2: Intratumoral PDT Induces PDP-based Enhancement of PD-1 Inhibition in Pancreatic Carcinoma
$228,869Kenneth K Wang · Massachusetts General Hospital · P01 · FY2022 · CA
Project 3: Mechanism-Based Design ofCombination Therapies for Pancreatic Cancer
$228,855Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2017 · CA
TCR-gene modified t-cells for adaptive immunotherapy
$228,750University Of Chicago · R21 · FY2003 · CA
TCR-gene modified t-cells for adaptive immunotherapy
$228,750University Of Chicago · R21 · FY2004 · CA
Mast cells and immunosuppression in skin cancer
$228,750Traci A Wilgus · Ohio State University · R21 · FY2012 · ES
Crosstalk between FceRI and MAVS signaling pathways in mast cells
$228,750Toshiaki Kawakami · La Jolla Institute For Immunology · R21 · FY2021 · AI
Genome-wide analysis of UV damage formation, repair, and mutagenesis
$228,735John J Wyrick · Washington State University · R21 · FY2017 · ES
Multiple Antigen-Engineered DC Immunization and IFNalpha-2b Boost for Metastatic
$228,712Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA
CORE--MELANOMA FACILITY
$228,564University Of Pennsylvania · P30 · FY2001 · CA
CORE--CANCER PHARMACOLOGY BIOANALYTICAL FACILITY
$228,564University Of Pennsylvania · P30 · FY2002 · CA
CORE--CLINICAL RESEARCH UNIT
$228,564University Of Pennsylvania · P30 · FY2001 · CA
CORE--MELANOMA FACILITY
$228,564University Of Pennsylvania · P30 · FY2002 · CA
CORE--CLINICAL RESEARCH UNIT
$228,564University Of Pennsylvania · P30 · FY2002 · CA
CORE--CANCER PHARMACOLOGY BIOANALYTICAL FACILITY
$228,564University Of Pennsylvania · P30 · FY2001 · CA
Vitiligo in Tyrosinase-specific TCR Transgenic Mice
$228,500University Of Virginia Charlottesville · R21 · FY2005 · AI
Administrative Core 1
$228,478Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Oncolytic Herpes Simplex Virus (HSV)1 as adjuvants for melanoma
$228,465Hongyan Guo · Louisiana State Univ Hsc Shreveport · P20 · FY2025 · GM